Please support the Ocular Melanoma research, treatment, and support.
Ocular melanoma is a form of melanoma that develops in the eye.
Approximately 2,000 Americans (or 6 people per 1 Million) are diagnosed with ocular melanoma each year.
Primary treatment of OM includes proton beam radiation, plaque therapy or removal of the eye, all of which can result in monocular vision or blindness of the OM eye, and ongoing eye issues.
50 percent of OM cases spread (metastasize) to other parts of the body, most often to liver or lungs. When this occurs, there is no cure to date and is ultimately fatal.
Regular chest and abdomen MRIs and CT scans are part of a patient's ongoing monitoring as metastasis can occur at any time in the patient's life, even after 5-10+ years post-diagnosis.
Routine dilated eye exams are critical for everyone for early detection of OM and other eye issues.
CURE OM
CURE OM (the Community United for Research and Education of Ocular Melanoma) is the MRF’s initiative to increase awareness, education and research funding for ocular melanoma, while improving the lives of people affected by this disease.
MRF's CURE OM provides funding of research, support, and new treatments and medical advances in treating primary and metastatic ocular melanoma.
If you think this page contains objectionable content, please inform the system administrator.